Catherine Eckford

The analysis from the USP provides a mitigation strategy for manufacturers and other stakeholders to improve reliability of medicine supply.

The cleaner method could greatly lower production costs and reduce carbon dioxide emissions resulting from ethylene oxide manufacturing.

Developed under MSL the gene therapy could provide a novel treatment option for paediatric patients at the earliest stage of the eye disease.

The monoclonal antibody treatment is now approved in the US for both diabetic macular oedema and wet, or neovascular AMD.

In its January meeting, the EMA’s human medicines committee recommended eight new medicines, including biosimilars and a new vaccine.

The committee’s approval of the one-time gene therapy means the healthcare inequalities in sickle cell disease can begin to be re-addressed.

The spectroscopy-based study highlights the importance of integrating data-driven approaches to enhance isomer discrimination.

Cell and Gene Therapy Catapult's (CGT Catapult) findings attest to the UK remaining “a highly attractive destination for clinical trials”.

The new acquisition by GSK could enable major advancement in the standard of care for GIST after nearly two decades.

The regulatory recommendation provides a targeted therapy option for eligible patients with the most common cancer in the UK.